Revolution Medicines Inc (RVMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 0 | 0 | 0 | 0 | 742 |
| Gross Profit | N/A | N/A | N/A | N/A | 742 |
| Operating Expenses | 216,310 | 175,712 | 156,643 | 140,859 | 180,725 |
| Operating Income | -216,310 | -175,712 | -156,643 | -140,859 | -179,983 |
| Other Income | 20,988 | 19,424 | 23,410 | 24,856 | 18,789 |
| Pre-tax Income | -195,322 | -156,288 | -133,233 | -116,003 | -161,194 |
| Income Tax | N/A | N/A | N/A | N/A | 343 |
| Net Income Continuous | -194,569 | -156,288 | -133,233 | -116,003 | -161,537 |
| Net Income | $-194,569 | $-156,288 | $-133,233 | $-116,003 | $-161,537 |
| EPS Basic Total Ops | -1.13 | -0.94 | -0.81 | -0.70 | -1.23 |
| EPS Basic Continuous Ops | -1.13 | -0.94 | -0.81 | -0.70 | -1.23 |
| EPS Diluted Total Ops | -1.13 | -0.94 | -0.81 | -0.70 | -1.23 |
| EPS Diluted Continuous Ops | -1.13 | -0.94 | -0.81 | -0.70 | -1.23 |
| EPS Diluted Before Non-Recurring Items | -1.12 | -0.94 | -0.81 | N/A | N/A |
| EBITDA(a) | $-221,749 | $-182,428 | $-164,748 | $-153,340 | $-185,758 |